BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, March 20, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Diabetes drug affects neurodegeneration, PD via immunity

June 27, 2018
By Anette Breindl

Bench Press: BioWorld looks at translational medicine

June 25, 2018
By Anette Breindl
Innate immune system activation appears to be linked to late-onset Alzheimer's disease (AD), which has led to speculation that infections might play a role in AD risk. Now, a team from the Mount Sinai School of Medicine has shown that individuals with AD had high levels of two separate herpes viruses in their brain. 
Read More

Tumor mutations can aid variant calling for germline

June 19, 2018
By Anette Breindl

Bench Press: BioWorld looks at translational medicine

June 18, 2018
By Anette Breindl
Researchers from the RV411 study group have reported that even when HIV-infected individuals started antiretroviral treatment (ART) within two weeks of infection, it could not prevent the establishment of a viral reservoir nor the occurrence of viral rebound if treatment was interrupted. 
Read More

Tumor mutations can aid variant calling for germline

June 18, 2018
By Anette Breindl
Researchers at the University of Washington have used information from acquired mutations in mismatch repair genes to assess whether the same mutations, when they occurred in the germline, put those that harbored them at risk of Lynch syndrome.
Read More

Brain sleepiness signature, links to memory identified

June 14, 2018
By Anette Breindl

Brain sleepiness signature, links to memory identified

June 14, 2018
By Anette Breindl
Birds do it. Bees do it. "Even jellyfish have this need," Qinghua Liu told BioWorld. Liu was referring, of course, to sleep, which he called "essentially... a black box, and one of the biggest mysteries of brain science."
Read More

Ribosome allows for multiple shots on giant goal

June 12, 2018
By Anette Breindl
ATLANTA – In the search for good antibacterial targets, new sites on validated structures are one sweet spot. Because they are on previously targeted structures, they are in principle validated targets. At the same time, targeting novel sites can turn back the clock in the antibiotic resistance race, particularly if there is no cross-resistance with existing antibiotics that target the same structure.
Read More

Bench Press: BioWorld looks at translational medicine

June 11, 2018
By Anette Breindl
A team from the Canadian institution The Hospital for Sick Children and the German Cancer Research Center have discovered that antibodies binding to the malaria parasite can interact with each other as well as with their parasite target, and that this interaction improved their affinity for the pathogen. 
Read More

Blood test predicts the chance of preterm labor

June 8, 2018
By Anette Breindl
Previous 1 2 … 127 128 129 130 131 132 133 134 135 … 401 402 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing